OHAMR Call for proposals 2026

General Information

• Project title: Structure-based design of a novel antimicrobial agent against multidrug-resistant bacterial infection
• Type: Project looking for partner
• Organisation: Institut d\'Investigació i Innovació Parc Taulí
• Country: Spain (ES)
• Career stage: Other.

Research area

• Scientific area(s) of the call:
  1. Topic 1: Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance.
• One Health Setting:

  H - Human Health

• Keywords:

  Structure-based drug design; Enzyme-based therapeutics; Biofilm; Advanced antimicrobial delivery systems

• Brief description of your expertise / expertise you are looking for:

  The Healthcare-Associated Infections Research Group aims to investigate the pathogenic mechanisms underlying some of the most prevalent infectious diseases in our setting, adopting a unified and integrative research framework that has been continuously developed since the 1980s. The group is part of I3PT, the research and innovation institute associated with Hospital Parc Taulí, a leading tertiary care hospital in Spain. This close connection between research and clinical practice enables strong translational impact, facilitating the study of infections from both molecular and clinical perspectives.

• Brief description of your project / the project you would like to join:

  Our project, tentatively titled “Structure-based design of a novel antimicrobial agent against multidrug-resistant bacterial infection” aims to advance next-generation antimicrobial strategies through the development of enzyme-based therapeutics with enhanced efficacy against resistant bacteria. Our consortium comprises two Spanish research groups with strong and complementary expertise in protein structural biology and molecular/clinical microbiology. To strengthen the proposal, we are seeking European partners with specialized expertise in: 1) Biofilm biology and eradication strategies, 2) Nanoparticle- or vesicle-based delivery systems 3) Technologies or reagents to potentiate antimicrobial activity, 4) Advance platforms for the assessment and validation of novel antimicrobial compounds. We welcome collaborations in contributing to a competitive, high-impact proposal.

Oscar Quijada

• Organisation: Institut d\'Investigació i Innovació Parc Taulí
• Position: Principal Investigator
• E-mail: projectesi3pt@tauli.cat
• Web: www.tauli.cat/es/institut/